West Nile neuroinvasive disease. Report of four cases in Northern Greece, 2018.
West Nile virus
biomarkers
neuroinvasive disease
Journal
Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
received:
18
07
2019
accepted:
24
02
2020
pubmed:
3
3
2020
medline:
13
7
2021
entrez:
3
3
2020
Statut:
ppublish
Résumé
West Nile virus (WNV) is a mosquito-borne RNA flavivirus which caused several epidemics worldwide. The year 2018 was a WNV record year for Europe, including Greece, with earlier and longer transmission season with higher than the previous number of cases. It has been proposed that some simple biochemical markers may be helpful for the recognition of WNV neuroinvasive disease, its differential from other neurological infectious diseases and prognosis. We describe four cases that suffered from WNV meningitis and/or encephalitis hospitalized in 2018 in a tertiary hospital in Thessaloniki, Greece, and investigate the importance of simple biomarkers for the recognition of WNV etiology.
Substances chimiques
Biomarkers
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1322-1325Informations de copyright
© 2020 Wiley Periodicals, Inc.
Références
Papa A, Danis K, Baka A, et al. Ongoing outbreak of West Nile virus infections in humans in Greece, July-August 2010. Euro Surveill. 2010;15(34):19644.
Danis K, Papa A, Theocharopoulos G, et al. Outbreak of West Nile virus infection in Greece, 2010. Emerg Infect Dis. 2011;17(10):1868-1872.
Papa A. West Nile virus infections in humans--focus on Greece. J Clin Virol. 2013;58(2):351-353.
European Centre for Disease Prevention and Control, West Nile virus risk assessment tool 2013: Stockholm.
Petersen LR, Brault AC, Nasci RS. West Nile virus: review of the literature. JAMA. 2013;310(3):308-315.
Lindsey NP, Staples JE, Lehman JA, Fischer M. Medical risk factors for severe West Nile Virus disease, United States, 2008-2010. Am J Trop Med Hyg. 2012;87(1):179-184.
Sejvar JJ, Marfin AA. Manifestations of West Nile neuroinvasive disease. Rev Med Virol. 2006;16(4):209-224.
Hage JE, Cunha BA. Are ESR/CRP ratios helpful in differentiating West Nile encephalitis from non-West Nile virus meningitis/encephalitis? Scand J Infect Dis. 2013;45(8):652-654.
Urošević A, Dulović O, Milošević B, et al. The importance of haematological and biochemical findings in patients with West Nile virus neuroinvasive disease. J Med Biochem. 2016;35(4):451-457.
Zak IT, Altinok D, Merline JR, Chander S, Kish KK. West Nile virus infection. Am J Roentgenol. 2005;184(3):957-961.
Ali M, Safriel Y, Sohi J, Llave A, Weathers S. West Nile virus infection: MR imaging findings in the nervous system. AJNR Am J Neuroradiol. 2005;26(2):289-297.
Anastasiadou A, Kakoulidis I, Butel D, Kehagia E, Papa A. Follow-up study of Greek patients with West Nile virus neuroinvasive disease. Int J Infect Dis. 2013;17(7):494-497.